newsfilter
← Latest News
PR Newswire·

Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage...